Browsing: Conditions

The Food and Drug Administration (FDA) has approved mFlusiva®, the first mRNA-based influenza vaccine, for adults aged 50 years and older. For persons aged 65 years and older, the vaccine received accelerated approval based on immune responses; continued approval in this age group is contingent upon verification and description of clinical benefit in a confirmatory…

N.Y. (WBNG) – Lyme disease is caused by the bacterium Borrelia burgdorferi and is spread through the bite of infected deer ticks. According to the Centers for Disease Control and Prevention, early treatment with antibiotics can be effective, while untreated infections can affect the joints, heart and nervous system